Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 937.00K | 566.00K | 613.00K | 607.00K | 510.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 937.00K | 566.00K | 613.00K | 607.00K | 510.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 937.00K | 566.00K | 613.00K | 607.00K | 510.00K |
| SG&A Expenses | 7.42M | 6.78M | 5.16M | 4.07M | 3.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.28M | 32.58M | 26.93M | 19.50M | 18.05M |
| Operating Income | -44.35M | -32.01M | -26.32M | -18.89M | -17.54M |
| Income Before Tax | -39.97M | -27.27M | -21.24M | -15.99M | -14.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.97M | -27.27M | -21.24M | -15.99M | -14.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.97M | -27.27M | -21.24M | -15.99M | -14.68M |
| EBIT | -44.35M | -32.01M | -26.32M | -18.89M | -17.54M |
| EBITDA | -44.31M | -31.97M | -26.27M | -18.88M | -17.53M |
| EPS Basic | -0.74 | -0.51 | -0.48 | -6.96 | -6.50 |
| Normalized Basic EPS | -0.46 | -0.32 | -0.29 | -3.31 | -3.05 |
| EPS Diluted | -0.74 | -0.51 | -0.48 | -6.96 | -6.50 |
| Normalized Diluted EPS | -0.46 | -0.32 | -0.29 | -3.31 | -3.05 |
| Average Basic Shares Outstanding | 53.77M | 53.62M | 45.70M | 3.02M | 3.01M |
| Average Diluted Shares Outstanding | 53.77M | 53.62M | 45.70M | 3.02M | 3.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |